Group I II III IV
Dose 0 mg/kg 750 mg/kg 400 mg/kg 750 + 400 mg/kg
Uterus Weight (g) Mean 55.06 47.36 52.70 54.62
SD 17.12 16.61 7.51 17.26
n 9 9 8 9
CL Mean 10.22 8.56 11.75 10.33
SD 2.64 2.88 1.16 2.6
n 9 9 8 9
Implants Mean 10.00 8.44 11.63 10.11
SD 2.83 2.79 1.19 2.42
n 9 9 8 9
Live Fetuses Mean 9.89 8.11 10.38 9.78
SD 2.8 2.85 1.6 3.27
n 9 9 8 9
Dead Fetuses Mean 0.00 0.00 0.00 0.00
SD 0.0 0.0 0.0 0.0
n 9 9 8 9
Early Resorptions Mean 0.11 0.00 1.00 0.33
SD 0.33 0.00 2.07 1.00
n 9 9 8 9
Late resorption Mean 0.11 0.33 0.38 0.00
SD 0.33 0.5 0.52 0.0
n 9 9 8 9
Group I: Control Group II: β Cyclodextrin, III: Tolbutamide IV: β Cyclodextrin + tolbutamide
Table 3: Summary of uterine data.